Research programme: hydrazone derivatives - LASSBio
Alternative Names: Dual cyclo-oxygenase/5-lipoxygenase inhibitors research programme - LASSBio; Hydrazone derivatives research programme - LASSBio; Research programme: dual cyclo-oxygenase/5-lipoxygenase inhibitors - LASSBioLatest Information Update: 29 Apr 2002
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action 5-lipoxygenase inhibitors; Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 30 Sep 1999 New profile
- 30 Sep 1999 Preclinical development for Inflammation in Brazil (Unknown route)